Bingyi Lin

1.3k citations

48 papers · 910 indexed · 2 hit papers · h-index 18

Impact in

Hepatology top 10%
Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism

Papers in ⓘ

Molecular Biology 16
- RNA modifications and cancer 5
- Glycosylation and Glycoproteins Research 5
Surgery 12
- Organ Transplantation Techniques and Outcomes 8

Co-authors: Shusen Zheng (21 shared papers)Lei Geng (14 shared papers)Liming Wu (6 shared papers)Wen Yi (7 shared papers)Ling Tang (1 shared paper)Rong Cai (1 shared paper)Lin Zhou (8 shared papers)Shuming Hu (1 shared paper)
Journals: International Journal of Medical Sciences (3 papers)Proceedings of the National Academy of Sciences (3 papers)World Journal of Gastroenterology (2 papers)BMB Reports (1 paper)Technology in Cancer Research & Treatment (1 paper)
Partner nations: China United States Macao

In The Last Decade

Bingyi Lin

46 papers receiving 900 citations

Hit Papers

align trajectories log scale

NRF2, a Superstar of Ferroptosis 2023 · 127 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 Antioxidants
2023 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Bingyi Lin

Since Specialization

Citations

This map shows the geographic impact of Bingyi Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingyi Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingyi Lin more than expected).

Fields of papers citing papers by Bingyi Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingyi Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingyi Lin. The network helps show where Bingyi Lin may publish in the future.

Co-authors

The 25 scholars most cited alongside Bingyi Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bingyi Lin Line = papers co-authored together Bingyi Lin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	NRF2, a Superstar of Ferroptosis Antioxidants ·Ruolan Yan, Bingyi Lin, Wenwei Jin, Ling Tang, Shuming Hu, Rong Cai Hit paper breakdown →	2023	127
2	YAP promotes multi-drug resistance and inhibits autophagy-related cell death in hepatocellular carcinoma via the RAC1-ROS-mTOR pathway Cancer Cell International ·Yuan Zhou, Yubo Wang, Wuhua Zhou, Tianchi Chen, Qinchuan Wu, Vikram Kumar Chutturghoon, Bingyi Lin, Lei Geng, Zhe Yang, Lin Zhou, Shusen Zheng	2019	92
3	O -GlcNAcylation promotes tumor immune evasion by inhibiting PD-L1 lysosomal degradation Proceedings of the National Academy of Sciences ·Qiang Zhu, Hongxing Wang, Siyuan Chai, Liang Xu, Bingyi Lin, Wen Yi, Liming Wu Hit paper breakdown →	2023	85
4	Altered Expression of Growth Factors and Cytokines in Keratoconus, Bullous Keratopathy and Diabetic Human Corneas Experimental Eye Research ·Mehrnoosh Saghizadeh, Marilyn Chwa, Annette M. Aoki, Bingyi Lin, Ashkan Pirouzmanesh, D. J. Brown, Alexander V. Ljubimov, M. Cristina Kenney	2001	61
5	Enzyme-responsive multifunctional peptide coating of gold nanorods improves tumor targeting and photothermal therapy efficacy Acta Biomaterialia ·Liming Wu, Bingyi Lin, Yang Huang, Jing Chen, Zhengwei Mao, Weilin Wang, Changyou Gao	2019	56
6	Overexpression of CXCL2 inhibits cell proliferation and promotes apoptosis in hepatocellular carcinoma BMB Reports ·Jun Ding, Kangdi Xu, Jie Zhang, Bingyi Lin, Yubo Wang, Shengyong Yin, Haiyang Xie, Lin Zhou, Shusen Zheng	2018	43
7	O-GlcNAcylation regulates epidermal growth factor receptor intracellular trafficking and signaling Proceedings of the National Academy of Sciences ·Liming Wu, Yaxian Cheng, Didi Geng, Zhiya Fan, Bingyi Lin, Qiang Zhu, Jingchao Li, Weijie Qin, Wen Yi	2022	37
8	One‐Step Enzymatic Labeling Reveals a Critical Role of O‐GlcNAcylation in Cell‐Cycle Progression and DNA Damage Response Angewandte Chemie International Edition ·Yinping Tian, Qiang Zhu, Zeyu Sun, Didi Geng, Bingyi Lin, Xiaoling Su, Jiahui He, Miao Guo, Hong Xu, Ye Zhao, Weijie Qin, Peng George Wang, Liuqing Wen, Wen Yi	2021	33
9	ER-α36: a novel biomarker and potential therapeutic target in breast cancer OncoTargets and Therapy ·Lisong Teng, Xingyun Su, Xin Xu, Guangliang Li, Bingyi Lin, Jiang Cao	2014	32
10	Remote ischemic perconditioning prevents liver transplantation-induced ischemia/reperfusion injury in rats: Role of ROS/RNS and eNOS World Journal of Gastroenterology ·Ning He, Junjun Jia, Jianhui Li, Yanfei Zhou, Bingyi Lin, Yifan Peng, Junjie Chen, Tian‐Chi Chen, Rongliang Tong, Li Jiang, Haiyang Xie, Lin Zhou, Shusen Zheng	2017	30
11	SNHG16 promotes hepatocellular carcinoma development via activating ECM receptor interaction pathway Hepatobiliary & pancreatic diseases international ·Qijun Zhang, Dazhi Li, Bingyi Lin, Lei Geng, Zhe Yang, Shu-Seng Zheng	2021	28
12	A modified protocol with rituximab and intravenous immunoglobulin in emergent ABO-incompatible liver transplantation for acute liver failure Hepatobiliary & pancreatic diseases international ·Shen Tian, Bingyi Lin, Junjun Jia, Zhuoyi Wang, Li Wang, Qi Ling, Lei Geng, Sheng Yan, Shusen Zheng	2014	27
13	High neutrophil-lymphocyte ratio indicates poor prognosis for acute-on-chronic liver failure after liver transplantation World Journal of Gastroenterology ·Bingyi Lin, Lin Zhou, Lei Geng, Zhiyun Zheng, Junjun Jia, Jing Zhang, Jia Yao, Shusen Zheng	2015	25
14	Association of p73 G4C14-to-A4T14 (GC/AT) polymorphism with breast cancer survival Carcinogenesis ·Huiqi Li, Lu Yao, Tao Ouyang, J. Li, T. Wang, Zhaoqing Fan, Tao Fan, Binhua Dong, Bingyi Lin, J. Li, Yuhuai Xie	2006	23
15	Single Nucleotide Polymorphisms in the Metastasis-associated in Colon Cancer-1 Gene Predict the Recurrence of Hepatocellular Carcinoma after Transplantation International Journal of Medical Sciences ·Zhiyun Zheng, Sheng Gao, Zhe Yang, Haiyang Xie, Cheng Zhang, Bingyi Lin, Liming Wu, Shusen Zheng, Lin Zhou	2014	20
16	The OGT–c-Myc–PDK2 axis rewires the TCA cycle and promotes colorectal tumor growth Cell Death and Differentiation ·Huijuan Wang, Jie Sun, Haofan Sun, Yifei Wang, Bingyi Lin, Liming Wu, Weijie Qin, Qiang Zhu, Wen Yi	2024	19
17	Role of overexpression of MACC1 and/or FAK in predicting prognosis of hepatocellular carcinoma after liver transplantation International Journal of Medical Sciences ·Sheng Gao, Bingyi Lin, Zhe Yang, Zhiyun Zheng, Zhikun Liu, Liming Wu, Haiyang Xie, Lin Zhou, Shusen Zheng	2014	18
18	SMYD2 Promotes Hepatocellular Carcinoma Progression by Reprogramming Glutamine Metabolism via c-Myc/GLS1 Axis Cells ·Kangdi Xu, Jun Ding, Lingfeng Zhou, Dazhi Li, Jia Luo, Wenchao Wang, Mingge Shang, Bingyi Lin, Lin Zhou, Shusen Zheng	2022	17
19	MicroRNA‑424 expression predicts tumor recurrence in patients with hepatocellular carcinoma following liver transplantation Oncology Letters ·Liming Wu, Feibiao Yang, Bingyi Lin, Xinhua Chen, Shengyong Yin, Feng Zhang, Haiyang Xie, Lin Zhou, Shusen Zheng	2018	13
20	Microplastic Particles Detected in Fetal Cord Blood, Placenta, and Meconium: A Pilot Study of Nine Mother–Infant Pairs in South China Toxics ·Minting Zhu, Xiaotian Li, Wei Lin, Lingfang Zeng, Pan Yang, Weigui Ni, Zhijian Chen, Bingyi Lin, Lijuan Lai, Zhongai Ouyang, Jingjie Fan	2024	12

About Bingyi Lin

Bingyi Lin is a scholar working on Molecular Biology, Surgery, Epidemiology, Cancer Research and Immunology, having authored 48 papers that have together received 910 indexed citations. Recurring topics across this work include Organ Transplantation Techniques and Outcomes (8 papers), Liver Disease Diagnosis and Treatment (6 papers), RNA modifications and cancer (5 papers), Glycosylation and Glycoproteins Research (5 papers), Immunotherapy and Immune Responses (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Nanoplatforms for cancer theranostics (3 papers). The work is most often cited by research in Hepatology (100 citations), Cancer Research (183 citations), Transplantation (28 citations), Oncology (190 citations) and Molecular Biology (455 citations). Bingyi Lin has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Shusen Zheng, Lei Geng, Liming Wu, Wen Yi, Ling Tang, Rong Cai, Lin Zhou, Shuming Hu, Qiang Zhu and Haiyang Xie. Their work appears in journals such as International Journal of Medical Sciences, Proceedings of the National Academy of Sciences, World Journal of Gastroenterology, BMB Reports and Technology in Cancer Research & Treatment.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact